Shree Ganesh Remedies Ltd commissions new plant at GIDC Anklehswar

Shree Ganesh Remedies Ltd has successfully commissioned a new Plant No.3B at GIDC Ankleshwar, with a installed production capacity 54 KL (Kilo litres) working volumes for its existing products.

The trial run of the plant was successfully completed on May 26, 2021 and the Company is expected to begin commercial production by early June, 2021.

Further the commissioning of new Plant No.3B has been funded through internal accruals and the Company continues to be a 'Zero Debt Entity'.

Shares of Shree Ganesh Remedies Ltd was last trading in BSE at Rs.328.95 as compared to the previous close of Rs. 330.85. The total number of shares traded during the day was 3315 in over 129 trades.

The stock hit an intraday high of Rs. 335 and intraday low of 324.05. The net turnover during the day was Rs. 1100484.

Source : Equity Bulls

Keywords